Sunday, November 8, 2015
- 9:00AM-11:00AM
-
Abstract Number: 138
Identification and Documentation of Secondary Osteoarthritis in Patients with Primary Inflammatory Arthritides Using a Patient MDHAQ/RAPID3 and a Physician Estimate of Joint Damage to Recognize Patient Complexity and Inform Management Decisions
Health Services Research Poster I: Diagnosis, Management and Treatment Strategies- 9:00AM-11:00AM
-
Abstract Number: 697
Identification Methods for Axial Spondyloarthritis in American Veterans
Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster I: Clinical Aspects and Assessments- 9:00AM-11:00AM
-
Abstract Number: 775
Identification of Candidate Items for Revised Classification Criteria for Systemic Lupus Erythematosus
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session I- 9:00AM-11:00AM
-
Abstract Number: 802
Identification of Cyclin-Dependent Kinase 1 As a Novel Regulator for Controlling Type I Interferon Signaling in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 788
Identification of Molecular Biomarkers to Distinguish Systemic Lupus Erythematosus with Skin Involvement from Discoid Lupus Erythematosus and Subacute Cutaneous Erythematosus: Provisional Results from Cross-Sectional Studies
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session I- 9:00AM-11:00AM
-
Abstract Number: 844
Identification of Subclinical Skin Involvement By High Frequency Ultrasound in Systemic Sclerosis Patients
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster I- 9:00AM-11:00AM
-
Abstract Number: 140
Identifying Psoriatic Arthritis and Ankylosing Spondylitis Patients Responsible for the Highest Costs of Care: Data from a Large US Cohort
Health Services Research Poster I: Diagnosis, Management and Treatment Strategies- 9:00AM-11:00AM
-
Abstract Number: 118
Identifying the Investment Needed to Generate a Durable Prednisone Dose Decrement
Health Services Research Poster I: Diagnosis, Management and Treatment Strategies- 9:00AM-11:00AM
-
Abstract Number: 742
IgM Antibodies Against Malondialdehyde and Phosphorylcholine Are T Cell Dependent and Strong Protection Markers for Atherosclerosis in SLE
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session I- 9:00AM-11:00AM
-
Abstract Number: 544
IL-6 May Have an Important Role in the Resistance to Anti-TNF Therapies of Human T-Lymphotropic Virus Type 1 (HTLV-1) Positive Rheumatoid Arthritis (RA) Patients; HTLV-1 Infected Cells Activate the Inflammatory Responses of RA Synovial Fibroblasts
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 83
Immediate Benefits of a Multidisciplinary Educational Program for Fibromyalgia on Patients’ Pain Related Self-Efficacy and Health Locus of Control
Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I- 9:00AM-11:00AM
-
Abstract Number: 531
Immune Responses to Mycobacterium Heat Shock Protein 70 Accompany Self-Reactivity to Human Bip in Rheumatoid Arthritis
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 529
Immunoglobulin-a and Immunoglobulin-G Isotypes of Anti-CCP Antibodies Are Present in the Sputum of Subjects at Risk for Future Development of RA
Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 516
Immunological and Ultrasound Characteristics of Patients with Rheumatoid Arthritis in Clinical Remission – Can We Use These to Predict Outcomes?